These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26969841)

  • 1. Systematic procedure for the classification of proven and potential teratogens for use in research.
    Eltonsy S; Martin B; Ferreira E; Blais L
    Birth Defects Res A Clin Mol Teratol; 2016 Apr; 106(4):285-97. PubMed ID: 26969841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common teratogenic medication exposures-a population-based study of pregnancies in the United States.
    Wang Y; Smolinski NE; Thai TN; Sarayani A; Ewig C; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol MFM; 2024 Jan; 6(1):101245. PubMed ID: 38061552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human teratogens: update 2010.
    Holmes LB
    Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
    Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenicity of recently introduced medications in human pregnancy.
    Lo WY; Friedman JM
    Obstet Gynecol; 2002 Sep; 100(3):465-73. PubMed ID: 12220765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks.
    van Gelder MM; de Jong-van den Berg LT; Roeleveld N
    Hum Reprod; 2014 Jan; 29(1):168-83. PubMed ID: 24108217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of reproductive life plans in identification of potentially teratogenic medication use: A pilot study.
    DiPietro Mager N; Mills C; Snelling A
    Birth; 2018 Mar; 45(1):50-54. PubMed ID: 29052257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on teratogens for pediatric healthcare providers.
    Valladares DA; Rasmussen SA
    Curr Opin Pediatr; 2022 Dec; 34(6):565-571. PubMed ID: 36081369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription of teratogenic medications in United States ambulatory practices.
    Schwarz EB; Maselli J; Norton M; Gonzales R
    Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential human teratogenicity of frequently prescribed drugs.
    Friedman JM; Little BB; Brent RL; Cordero JF; Hanson JW; Shepard TH
    Obstet Gynecol; 1990 Apr; 75(4):594-9. PubMed ID: 2314777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provision of potentially teratogenic medications to female veterans of childbearing age.
    Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB
    Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk.
    Thorpe PG; Gilboa SM; Hernandez-Diaz S; Lind J; Cragan JD; Briggs G; Kweder S; Friedman JM; Mitchell AA; Honein MA;
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):1013-8. PubMed ID: 23893932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.
    Teratology; 1994 Jun; 49(6):446-7. PubMed ID: 7747265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memories of the Teratology Society: 1972-2020.
    Holmes LB
    Birth Defects Res; 2020 Jul; 112(12):935-941. PubMed ID: 32686350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counselling pregnant women at the crossroads of Europe and Asia: effect of Teratology Information Service in Turkey.
    Kaplan YC; Karadaş B; Küçüksolak G; Ediz B; Demir Ö; Sozmen K; Nordeng H
    Int J Clin Pharm; 2017 Aug; 39(4):783-790. PubMed ID: 28626851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study.
    Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Straus SM; Stricker BH
    BJOG; 2015 Jul; 122(8):1119-29. PubMed ID: 25316196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical need for clinical decision support systems for identification and management of teratogenic medications.
    DiPietro Mager NA
    J Am Pharm Assoc (2003); 2019; 59(2S):S18-S20. PubMed ID: 30737104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian hierarchical methods in the detection of potentially teratogenic first-trimester medications.
    Cavadino A; Prieto-Merino D; Morris JK
    Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):337-346. PubMed ID: 31908100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011.
    Peters SL; Lind JN; Humphrey JR; Friedman JM; Honein MA; Tassinari MS; Moore CA; Mathis LL; Broussard CS
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):324-8. PubMed ID: 23359404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medication.
    Luteijn JM; Morris JK; Garne E; Given J; de Jong-van den Berg L; Addor MC; Bakker M; Barisic I; Gatt M; Klungsoyr K; Latos-Bielenska A; Lelong N; Nelen V; Neville A; O'Mahony M; Pierini A; Tucker D; de Walle H; Wiesel A; Loane M; Dolk H
    Br J Clin Pharmacol; 2016 Oct; 82(4):1110-22. PubMed ID: 27353147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.